Bausch Health Companies Inc. (BHC.TO)

Trade BHC.TO now with
6/8/2021 7:00:50 AM Bausch + Lomb And Lochan Agree To Develop Next-Generation Of EyeTELLIGENCE Clinical Decision Support Software
6/2/2021 7:25:15 AM Bausch Health And Clearside Biomedical Announce FDA Filing Acceptance For XIPERE; Assigns PDUFA Action Date Of Oct 30
5/27/2021 7:16:32 AM Bausch Health To Reduce Debt By $100 Mln Using Cash Generated From Operations
5/24/2021 8:25:49 AM Bausch Health Launches Offering Of $1.6 Bln Of New Senior Secured Notes Due 2028
5/24/2021 8:24:07 AM Bausch Health Commences Cash Tender Offer For 7% Senior Secured Notes Due 2024
5/4/2021 7:23:54 AM Bausch Health Companies Q1 Net Loss $610 Mln Vs. Net Loss $152 Mln Last Year
5/3/2021 7:14:34 AM Bausch Health To Reduce Debt By $100 Mln Using Cash Generated From Operations
4/29/2021 7:29:44 AM Bausch + Lomb To Present New Scientific Data And Analyses On Products And Pipeline Programs
4/16/2021 1:38:37 AM Bausch Health And Nicox: VYZULTA 0.024% Gets Approval From Brazilian Health Regulatory Agency
4/13/2021 7:04:54 AM Bausch + Lomb Says Topline Results From Phase 3 Trial Of NOV03 Meets Primary And Secondary Endpoints
4/8/2021 7:06:20 AM Bausch Health Reports U.S. Launch Of Novel Daily Over-the-counter Probiotic Supplement, ENVIVE
4/7/2021 7:34:05 AM Bausch + Lomb: FDA Approves ClearVisc Dispersive Ophthalmic Viscosurgical Device
4/7/2021 7:11:36 AM Bausch Health Companies Plans To Reduce Debt By $100 Mln Through Redemption Of Senior Secured Notes
3/31/2021 8:09:45 AM Bausch Health Companies, Affiliates To Sell All Equity Interests In Amoun Pharmaceutical To Abu-Dhabi Based ADQ
3/31/2021 8:08:02 AM Bausch Health Agrees To Sell Amoun Pharma For Total Gross Consideration Of About $740 Mln